Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/19363859

Download in:

View as

General Info

PMID
19363859